학술논문
The Response of Pharmaceutical Manufacturers to the Provisions of the ACA
이용수 40
- 영문명
- 발행기관
- People & Global Business Association
- 저자명
- Yangmei Wang Tiankai Wang Alan J. Dubinsky
- 간행물 정보
- 『Global Business and Finance Review』Vol.19 No.2, 35~41쪽, 전체 7쪽
- 주제분류
- 경제경영 > 경영학
- 파일형태
- 발행일자
- 2014.12.31
4,000원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.
국문 초록
영문 초록
The provisions of the Patient Protection and Affordable Care Act of 2010 (the ACA) engendered a number of effects on pharmaceutical manufacturers, including the annual fee, mandated Medicaid drugs rebates, and Medicare prescription drug coverage “donut hole” relief. The authors conduct theoretical and empirical analyses to assess the consequences of the provisions. Both theoretical and empirical analyses show that the provisions have positive correlations with increased prices for branded prescription drugs. These findings reveal that pharmaceutical manufacturers shift drug costs to patients.
목차
Ⅰ. Introduction
Ⅱ. Conceptual Analysis
Ⅲ. Empirical Methodology
Ⅳ. Limitations and Discussion
Ⅴ. Conclusion
해당간행물 수록 논문
- Understanding FERPA Implications of the Family Educational Rights and Privacy Act
- The Response of Pharmaceutical Manufacturers to the Provisions of the ACA
- Overreaction around DJIA Milestone Events : Evidence from an Intraday Analysis
- The Dynamic Interaction among Remittances and Macroeconomic Variables : Evidence from Sub-Saharan Africa
- The Association between Earnings News and The Timing of Annual Earnings Announcements
- Day-of-the-Week Trading Patterns of Individual and Institutional Investors
참고문헌
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!